The SARS-CoV-2 (2019-nCoV) Nucleocapsid Rabbit Monoclonal Antibody is a highly specific and sensitive antibody designed to detect the nucleocapsid (N) protein of the SARS-CoV-2 virus, which plays a crucial role in viral replication and genome packaging. This antibody is widely used in research and diagnostic applications related to COVID-19, including viral detection, pathogenesis studies, and vaccine development. Suitable for techniques such as Western blotting, ELISA, and immunohistochemistry, it offers robust performance and reliable detection of SARS-CoV-2 in infected cells or tissue samples.
GRM420
GRM420 reacts 2019-nCov Nucleocapsid Protein.
A recombinant 2019-nCov Nucleocapsid Protein expressed in E.coli.
Sandwich ELISA assay as a capture antibody, pair with anti-2019-nCov NP Rabbit/Human Chimeric monoclonal antibody, Clone GRMH03.
Validated in COVID-19 patient samples.
None
Research Use Only
Stable for 1 Year at -20.0°C from date of receipt
At Genebiosolution, our commitment lies in crafting cutting-edge solutions for researchers, clinicians, and diagnostic laboratories seeking excellence in immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). With a focus on quality, reliability, and accuracy, our products empower advancements in molecular diagnostics and research methodologies.
